{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T09:25:31Z","timestamp":1774085131291,"version":"3.50.1"},"reference-count":38,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2016,11,26]],"date-time":"2016-11-26T00:00:00Z","timestamp":1480118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"IRCCS Burlo Garofolo","award":["RC07\/08"],"award-info":[{"award-number":["RC07\/08"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The scientific community still faces the challenge of developing strategies to cure HIV-1. One of these pursued strategies is the development of immunotherapeutic vaccines based on dendritic cells (DCs), pulsed with the virus, that aim to boost HIV-1 specific immune response. We aimed to review DCs-based therapeutic vaccines reports and critically assess evidence to gain insights for the improvement of these strategies. We performed a systematic review, followed by meta-analysis and meta-regression, of clinical trial reports. Twelve studies were selected for meta-analysis. The experimental vaccines had low efficiency, with an overall success rate around 38% (95% confidence interval = 26.7%\u201351.3%). Protocols differed according to antigen choice, DC culture method, and doses, although multivariate analysis did not show an influence of any of them on overall success rate. The DC-based vaccines elicited at least some immunogenicity, that was sometimes associated with plasmatic viral load transient control. The protocols included both na\u00efve and antiretroviral therapy (ART)-experienced individuals, and used different criteria for assessing vaccine efficacy. Although the vaccines did not work as expected, they are proof of concept that immune responses can be boosted against HIV-1. Protocol standardization and use of auxiliary approaches, such as latent HIV-1 reservoir activation and patient genomics are paramount for fine-tuning future HIV-1 cure strategies.<\/jats:p>","DOI":"10.3390\/ijms17121985","type":"journal-article","created":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T10:25:22Z","timestamp":1480328722000},"page":"1985","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Dendritic Cell-Based Immunotherapies to Fight HIV: How Far from a Success Story? A Systematic Review and Meta-Analysis"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2143-9701","authenticated-orcid":false,"given":"Antonio","family":"Coelho","sequence":"first","affiliation":[{"name":"Department of Genetics, Federal University of Pernambuco, Avenida da Engenharia, Cidade Universit\u00e1ria, Recife 50740-600, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"De Moura","sequence":"additional","affiliation":[{"name":"Department of Genetics, Federal University of Pernambuco, Avenida da Engenharia, Cidade Universit\u00e1ria, Recife 50740-600, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anselmo","family":"Kamada","sequence":"additional","affiliation":[{"name":"Department of Genetics, Federal University of Pernambuco, Avenida da Engenharia, Cidade Universit\u00e1ria, Recife 50740-600, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronaldo","family":"Da Silva","sequence":"additional","affiliation":[{"name":"Laboratory of Immunopathology Keizo Asami (LIKA), Federal University of Pernambuco, Avenida da Engenharia, Cidade Universit\u00e1ria, Recife 50740-600, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4760-2466","authenticated-orcid":false,"given":"Rafael","family":"Guimar\u00e3es","sequence":"additional","affiliation":[{"name":"Department of Genetics, Federal University of Pernambuco, Avenida da Engenharia, Cidade Universit\u00e1ria, Recife 50740-600, Brazil"},{"name":"Laboratory of Immunopathology Keizo Asami (LIKA), Federal University of Pernambuco, Avenida da Engenharia, Cidade Universit\u00e1ria, Recife 50740-600, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas","family":"Brand\u00e3o","sequence":"additional","affiliation":[{"name":"Laboratory of Immunopathology Keizo Asami (LIKA), Federal University of Pernambuco, Avenida da Engenharia, Cidade Universit\u00e1ria, Recife 50740-600, Brazil"},{"name":"Department of Pathology, Federal University of Pernambuco, Avenida Prof. Moraes Rego, 1235, Cidade Universit\u00e1ria, Recife 50670-901, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz","family":"De Alencar","sequence":"additional","affiliation":[{"name":"Department of Tropical Medicine, Federal University of Pernambuco. Avenida Prof. Moraes Rego, 1235, Cidade Universit\u00e1ria, Recife 50670-901, Brazil"},{"name":"Instituto de Medicina Integral Professor Fernando Figueira (IMIP), Boa Vista, Recife 50070-550, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Crovella","sequence":"additional","affiliation":[{"name":"IRCCS Burlo Garofolo and University of Trieste, Via dell\u2019 Istria 65\/1, Trieste 34137, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2016,11,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1002\/eji.200737400","article-title":"Dendritic cells: Understanding immunogenicity","volume":"3","author":"Steinman","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-065X.2008.00737.x","article-title":"Innate immunity to virus infection","volume":"227","author":"Takeuchi","year":"2009","journal-title":"Immunol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"R355","DOI":"10.1016\/j.cub.2009.03.012","article-title":"Orchestration of the immune response by dendritic cells","volume":"19","author":"Buckwalter","year":"2009","journal-title":"Curr. Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nri1960","article-title":"Dendritic-cell interactions with HIV: Infection and viral dissemination","volume":"6","author":"Wu","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/jmv.20612","article-title":"Peptide-loaded dendritic-cell vaccination followed by treatment interruption for chronic HIV-1 infection: A phase 1 trial","volume":"78","author":"Ide","year":"2006","journal-title":"J. Med. Virol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/infdis\/jiv582","article-title":"Therapeutic vaccination with dendritic cells loaded with autologous HIV type 1-infected apoptotic cells","volume":"213","author":"Macatangay","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1089\/aid.1998.14.551","article-title":"A pilot clinical trial of HIV antigen-pulsed allogeneic and autologous dendritic cell therapy in HIV-infected patients","volume":"14","author":"Kundu","year":"1998","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm1147","article-title":"Therapeutic dendritic-cell vaccine for chronic HIV-1 infection","volume":"10","author":"Lu","year":"2004","journal-title":"Nat. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1086\/429340","article-title":"Therapeutic immunization with dendritic cells loaded with heat-inactivated autologous HIV-1 in patients with chronic HIV-1 infection","volume":"191","author":"Garcia","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"6088","DOI":"10.1016\/j.vaccine.2009.05.016","article-title":"A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy","volume":"27","author":"Gandhi","year":"2009","journal-title":"Vaccine"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/infdis\/jiq077","article-title":"A therapeutic dendritic cell-based vaccine for HIV-1 infection","volume":"203","author":"Garcia","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"166ra2","DOI":"10.1126\/scitranslmed.3004682","article-title":"A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication","volume":"5","author":"Garcia","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"ref_13","first-page":"1329","article-title":"Induction of novel CD8+ T-cell responses during chronic untreated HIV-1 infection by immunization with subdominant cytotoxic T-lymphocyte epitopes","volume":"23","author":"Kloverpris","year":"2009","journal-title":"Acquir. Immune Defic. Syndr."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1002\/eji.201344433","article-title":"Dendritic cell-based therapeutic vaccine elicits polyfunctional HIV-specific T-cell immunity associated with control of viral load","volume":"44","author":"Levy","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.clim.2011.10.010","article-title":"A phase I\/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption","volume":"142","author":"Allard","year":"2012","journal-title":"Clin. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Jacobson, J.M., Routy, J.P., Welles, S., DeBenedette, M., Tcherepanova, I., Angel, J.B., Asmuth, D.M., Stein, D.K., Baril, J.G., and McKellar, M. (2016). Dendritic cell immunotherapy for HIV-1 infection using autologous HIV-1 RNA: A randomized, double-blind, placebo-controlled clinical trial. J. Acquir. Immune Defic. Syndr.","DOI":"10.1097\/QAI.0000000000000926"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/CVI.00141-07","article-title":"Dendritic cell function during chronic hepatitis C virus and human immunodeficiency virus type 1 infection","volume":"14","author":"Fan","year":"2007","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1189\/jlb.1107795","article-title":"Maturation of dendritic cells for enhanced activation of anti-HIV-1 CD8+ T cell immunity","volume":"83","author":"Huang","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1089\/aid.2007.0111","article-title":"Characterization of near full-length genomes of HIV type 1 strains in Denmark: Basis for a universal therapeutic vaccine","volume":"23","author":"Andresen","year":"2007","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"D784","DOI":"10.1093\/nar\/gku1166","article-title":"Allele frequency net 2015 update: New features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations","volume":"43","author":"Takeshita","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1099\/vir.0.19152-0","article-title":"Optimization and immune recognition of multiple novel conserved HLA-A2, human immunodeficiency virus type 1-specific CTL epitopes","volume":"84","author":"Corbet","year":"2003","journal-title":"J. Gen. Virol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0161-5890(02)00023-8","article-title":"HLA and in vitro susceptibility to HIV infection","volume":"38","year":"2002","journal-title":"Mol. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/j.vaccine.2009.12.056","article-title":"Polymorphisms in innate immunity genes and patients response to dendritic cell-based HIV immuno-treatment","volume":"28","author":"Segat","year":"2010","journal-title":"Vaccine"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"512","DOI":"10.4161\/hv.27125","article-title":"Host genomic HIV restriction factors modulate the response to dendritic cell-based treatment against HIV-1","volume":"10","author":"Pontillo","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"18938","DOI":"10.7448\/IAS.17.1.18938","article-title":"Exome analysis of HIV patients submitted to dendritic cells therapeutic vaccine reveals an association of CNOT1 gene with response to the treatment","volume":"17","author":"Moura","year":"2014","journal-title":"J. Int. AIDS Soc."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Moura Rodrigues, R., Plana, M., Garcia, F., Zupin, L., Kuhn, L., and Crovella, S. (2016). Genome-wide scan in two groups of HIV-infected patients treated with dendritic cell-based immunotherapy. Immunol. Res.","DOI":"10.1007\/s12026-016-8875-x"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1016\/j.vaccine.2015.04.047","article-title":"DC immunotherapy in HIV-1 infection induces a major blood transcriptome shift","volume":"33","author":"Andeweg","year":"2015","journal-title":"Vaccine"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.1016\/j.vaccine.2011.07.043","article-title":"Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection Workshop in dendritic cell-based vaccine clinical trials in HIV-1","volume":"29","author":"Garcia","year":"2011","journal-title":"Vaccine"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"20497","DOI":"10.7448\/IAS.18.1.20497","article-title":"Evaluating the efficacy of therapeutic HIV vaccines through analytical treatment interruptions","volume":"18","author":"Graziani","year":"2015","journal-title":"J. Int. AIDS Soc."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1086\/428777","article-title":"Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1","volume":"191","author":"Strain","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11904-012-0113-0","article-title":"Should we treat acute HIV infection?","volume":"9","author":"Markowitz","year":"2012","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-2796.2008.02047.x","article-title":"Dendritic cell-based human immunodeficiency virus vaccine","volume":"265","author":"Rinaldo","year":"2009","journal-title":"J. Intern. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/cells1020111","article-title":"ELISPOT assay for monitoring cytotoxic T lymphocytes (CTL) activity in cancer vaccine clinical trials","volume":"1","author":"Malyguine","year":"2012","journal-title":"Cells"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1586\/erv.10.49","article-title":"New flow cytometric assays for monitoring cell-mediated cytotoxicity","volume":"9","author":"Zaritskaya","year":"2010","journal-title":"Expert Rev. Vaccines"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"9189","DOI":"10.1128\/JVI.01062-15","article-title":"HIV-1 Reservoir dynamics after vaccination and antiretroviral therapy interruption are associated with dendritic cell vaccine-induced T cell responses","volume":"89","author":"Andres","year":"2015","journal-title":"J. Virol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1016\/S2352-3018(16)30055-8","article-title":"Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): A single-arm, phase 1B\/2A trial","volume":"3","author":"Leth","year":"2016","journal-title":"Lancet HIV"},{"key":"ref_37","unstructured":"Imperial College London Research in Viral Eradication of HIV Reservoirs (RIVER), Available online: http:\/\/clinicaltrials.gov\/show\/NCT00004451 NLM Identifier: NCT00004451."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cct.2006.04.004","article-title":"Random-effects model for meta-analysis of clinical trials: An update","volume":"28","author":"DerSimonian","year":"2007","journal-title":"Contemp. Clin. Trials"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/17\/12\/1985\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:27:32Z","timestamp":1760210852000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/17\/12\/1985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,26]]},"references-count":38,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12]]}},"alternative-id":["ijms17121985"],"URL":"https:\/\/doi.org\/10.3390\/ijms17121985","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,26]]}}}